UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047154
Receipt number R000053765
Scientific Title The efficacy of Subcutaneous Incision of the Fistula Tract and Internal Sphincterotomy(SIFT-IS) for transsphincteric anal fistulas
Date of disclosure of the study information 2022/03/15
Last modified on 2022/03/10 21:41:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The efficacy of Subcutaneous Incision of the Fistula Tract and Internal Sphincterotomy(SIFT-IS) for transsphincteric anal fistulas

Acronym

The efficacy of SIFT-IS for anal fistulas

Scientific Title

The efficacy of Subcutaneous Incision of the Fistula Tract and Internal Sphincterotomy(SIFT-IS) for transsphincteric anal fistulas

Scientific Title:Acronym

The efficacy of SIFT-IS for anal fistulas

Region

Japan


Condition

Condition

Transsphincteric anal fistula

Classification by specialty

Surgery in general

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the efficacy of SIFT-IS in patients with transsphincteric anal fistulas

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Postoperative healing rate at 16 weeks

Key secondary outcomes

Healing time,postoperative complications,and clinical continence status


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Performing SIFT-IS for transsphincteric anal fistula

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Transsphincteric anal fistula

Key exclusion criteria

Complicated fistulas(multiple fistulas,recurrent fistula,and horseshoe fistula)
IBD associated fistulas

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Rikisaburo
Middle name
Last name Sahara

Organization

Makita General Hospital

Division name

Division of Coloproctology

Zip code

143-8505

Address

4-22-1 Nishikamata,Ohta-ku,Tokyo 143-8505,Japan

TEL

03(5748)5020

Email

riki58sahara@gmail.com


Public contact

Name of contact person

1st name Koji
Middle name
Last name Morimoto

Organization

Nishiarai Coloproctology Clinic

Division name

Division of Coloproctology

Zip code

121-0815

Address

3-7-13 Shimane,Adachi-ku,Tokyo 121-0815 Japan

TEL

03(3883)2020

Homepage URL


Email

morimo69@gmail.com


Sponsor or person

Institute

JCHO Tokyo Yamate Mrdical Center

Institute

Department

Personal name



Funding Source

Organization

Nishiarai Coloproctology Clinic

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

JCHO Tokyo Yamate Medical Center

Address

3-22-1 Hyakunin-cho,Shinjuku-ku,Tokyo 169-0073,Japan

Tel

03(3364)0251

Email

morimo69@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 03 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2016 Year 01 Month 01 Day

Date of IRB

2021 Year 09 Month 30 Day

Anticipated trial start date

2016 Year 01 Month 01 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 03 Month 11 Day

Last modified on

2022 Year 03 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053765